• Tanzania

• Tanzania

The United Republic of Tanzania is missing more than 59% of its 160,000 people estimated to have developed drug-sensitive TB in 2016. During the same year, more than 93% of its 2,600 people estimated to have developed drug-resistant TB were also missed by the health system.

To find more of its missing people with TB, Tanzania is expanding the implementation of its Quality Improvement (QI) toolkit across the country through which screening in health facilities is intensified and high-risk groups are being systematically screened. In order to strengthen sputum referrals from the peripheral health facilities to health facilities with GeneXpert, more than 100 motorcycles (Bodaboda) riders will be supported. The country will also roll out the Integrated Management of Childhood Illness (IMCI) through distance learning. Tanzania is also expanding engagement with private health care providers through integration with Reproductive, Maternal, Newborn, Child and Adolescent Health and Nutrition (RMNCAH) services in reviewing the Child TB Guide for Accredited Drug Dispensing Outlets (ADDOs) and traditional healers in areas of low TB case detection. Private health facilities in select urban regions will further be engaged.

To strengthen the laboratory diagnostic network, Tanzania is rolling out iLED microscopes in sites without GeneXpert. Systematic screening of communities and high-risk groups will be expanded through the roll-out of sputum fixers in regions with the lowest TB case detection as well as sensitization campaigns conducted among miners, slums, schools and community health volunteers. Finally, TB case finding among PLHIVs, prisoners, and people who inject drugs will be intensified through the procurement of additional GeneXpert machines.